Cyclopharm says radioactive gas could help diagnose COVID-19

Nuclear medicine company Cyclopharm (ASX:CYC)says its radioactive gas could be useful to diagnose cases of COVID-19.

It has developed a gas made of radioactive carbon that is inhaled via a breathing apparatus. The carbon is picked up by gamma imaging to identify pulmonary embolisms, or arterial blockages in the lungs.

But the company says it could also be used to identify damage and inflammation to the lining of the lung caused by coronavirus, in addition to the current method of lab testing samples.

“Currently, the primary diagnostic method for determining the presence of the COVID-19 virus is a laboratory test,” the company said.

“We are receiving reports of an increase in the use of Technegas to differentiate between COVID-19 and pulmonary embolism where laboratory tests results cannot be attained quickly.”

https://**promotion blocked**/health/cyclopharm-says-radioactive-gas-could-help-diagnose-covid-19/